89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation in a dose-dependent manner and role of IL-2 receptor-binding
van Oordt, C.W. Menke-van der Houven, van Brummelen, E., Nayak, T., Huisman, M., de Wit- van der Veen, L., Mulder, E., Hoekstra, O., Stokkel, M., van Dongen, G.A., Verheul, H.M., Feilke, M., Guizani, C., Guarin, E., Evers, S., Saro, J., Schellens, J.H.M.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine
Tabernero, J, Homicsko, K, Schellens, J.H, Hoekstra, O, Van der Veen, L, Melero, I, és, G. Argil, Mau-Sorensen, M, Angevin, E, Joensuu, H, Van Brummelen, E, van Oordt, C.W. Menke-van der Houven, Nayak, T, Romagnoli, S, Reis, B, Brossard, S. Soehrman, Evers, S, Saro, J, Verheul, H, Lassen, U
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Gebhart, G., Lamberts, L.E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Oyen, W.J.G., Vugts, D.J., Hoekstra, O.S., Schröder, C.P., Menke-van der Houven van Oordt, C.W., Guiot, T., Brouwers, A.H., Awada, A., de Vries, E.G.E., Flamen, P.
Published in Annals of oncology (01.04.2016)
Published in Annals of oncology (01.04.2016)
Get full text
Journal Article
338TiP EORTC-2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA)
Ignatiadis, M., Saloustros, E., Joaquim, A., Casas, J.G., Kelly, C.M., Razis, E., Lambertini, M., Foukakis, T., Fehr, M., Menke-van der Houven van Oordt, C.W., Crestani, T. Antoniolli, Simon, S. Pernas, Bussels, B., Hanssens, M., Neven, P., Xenophontos, E., Meyskens, T., Bidard, F.C., Poncet, C., Janni, W.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
724O EO2401 (E) peptide immunotherapy + nivolumab (N) in adrenocortical carcinoma (ACC) and metastatic pheochromocytoma/paraganglioma (MPP): EOADR1-19/SPENCER
Baudin, E., Grisanti, S., Menke-van der Houven van Oordt, C.W., Haak, H., Castillon, J. Capdevila, Fassnacht, M., Subbiah, V., Jimenez, C., Fouchardiere, C. de la, Yachnin, J., Granberg, D., Kroiss, M., Daugaard, K.G., Cosentini, D., Lamartina, L., Paillarse, J-M., Aubergeon, L., Fagerberg, J., Chêne, L., Berruti, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2MO EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma/paraganglioma (MPP): Phase I/II SPENCER study
Baudin, E., Grisanti, S., Fassnacht, M., Menke-van der Houven van Oordt, C.W., Haak, H., de la Fouchardiere, C., Subbiah, V., Jimenez, C., Capdevila Castillon, J., Granberg, D., Daugaard, K.G., Kroiss, M., Cosentini, D., Kimpel, O., Lamartina, L., Hadoux, J., Paillarse, J-M., Chêne, L., Fagerberg, J., Berruti, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer
Iqbal, R., Mo, C., Cysouw, M.C.F., Glaudemans, A.W.J.M., Hospers, G.A.P., Schroder, C.P., Venema, C.C.M., Menke-van der Houven van Oordt, C.W.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article
346 (PB-141) - The influence of various adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype
Kramer, I., Schaapveld, M., Oldenburg, H.S.A., Sonke, G.S., Mccool, D., Van Leeuwen, F.E., Van de Vijver, K.K., Russell, N.S., Linn, S.C., Siesling, S., Menke- van der Houven van Oordt, C.W., Schmidt, M.K.
Published in European journal of cancer (1990) (01.04.2018)
Published in European journal of cancer (1990) (01.04.2018)
Get full text
Journal Article
The influence of various adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype
Kramer, I., Schaapveld, M., Oldenburg, H.S.A., Sonke, G.S., Mccool, D., Van Leeuwen, F.E., Van de Vijver, K.K., Russell, N.S., Linn, S.C., Siesling, S., Menke- van der Houven van Oordt, C.W., Schmidt, M.K.
Published in European journal of cancer (1990) (01.04.2018)
Published in European journal of cancer (1990) (01.04.2018)
Get full text
Journal Article
Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors
Plummer, R, Sanborn, R E, de Vries, E G E, Lorusso, P, Arkenau, H-T, Uboha, N, Wydmanski, J, Fidler, M J, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, K A, El-Khoueiry, A B, Menke-van der Houven van Oordt, C W, Thistlethwaite, F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Assessment of cfDNA in patients with metastatic colorectal cancer treated with cetuximab monotherapy
Angus, L., van Helden, E.J., van Es, S.C., Boon, E., van Herpen, C.M.L., de Groot, D.J., de Vries, E.G.E., Menke-van der Houven van Oordt, C.W., Sleijfer, S., Verheul, H.M., Jansen, M.P.H.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas
Moek, K L, Waaijer, S J H, Kok, I C, Suurs, F V, Brouwers, A, Menke-van der Houven van Oordt, C W, Wind, T T, Gietema, J A, Schroder, C P, Mahesh, S V K, Jorritsma-Smit, A, Lub-De Hooge, M N, Fehrmann, R S N, de Groot, D J, de Vries, E G E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Pet-Imaging with 89Zr-Labeled Anti-Mesothelin (Msln) Antibody in Patients with Pancreatic Cancer (Pc) or Ovarian Cancer (Oc)
Lamberts, L.E., Menke-van der Houven van Oordt, C.W., Bensch, F., Voortman, J., Hoekstra, O.S., Maslyar, D., Williams, S.P., Fine, B.M., Bongaerts, A.H., Gietema, J.A., Schroder, C.P., Te Weele, E.J. r, Hooge, M.N. Lub-De, Verheul, H.M., Sanabria, S., Glaudemans, A.W.J.M., De Vries, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1627PPET-IMAGING WITH 89ZR-LABELED ANTI-MESOTHELIN (MSLN) ANTIBODY IN PATIENTS WITH PANCREATIC CANCER (PC) OR OVARIAN CANCER (OC)
Lamberts, L.E., Menke-van der Houven van Oordt, C.W., Bensch, F., Voortman, J., Hoekstra, O.S., Maslyar, D., Williams, S.P., Fine, B.M., Bongaerts, A.H., Gietema, J.A., Schroder, C.P., Weele, E.J. Ter, Hooge, M.N. Lub-De, Verheul, H.M., Sanabria, S., Glaudemans, A.W.J.M., De Vries, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article